DH-001

N/A

Report date: 2023/12/11 13:39:59
NME

Base Information

Drug NameDH-001
Drug Alias NameDH-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDrug intoxicationsHeart FailureCardiotoxicity +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesMonyan Pharmaceutical (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMonyan Pharmaceutical (Shanghai) Co LtdZhejiang Dinghui Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsDrug intoxicationsHeart FailureCardiotoxicity +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A